Validation of a multiplex immunoassay for serum angiogenic factors as biomarkers for aggressive prostate cancer-Reference-Cited by-同舟云学术

Validation of a multiplex immunoassay for serum angiogenic factors as biomarkers for aggressive prostate cancer

Published:2012-10 Issue:19-20 Volume:413 Page:1506-1511
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Li Danni,Chiu Hanching,Gupta Vinita,Chan Daniel W.

Publisher

Elsevier BV

Reference38 articles.

1. Cancer facts & figures 2009,2009

2. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management;Cooperberg;J Clin Oncol,2004

3. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma;Weidner;Am J Pathol,1993

4. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer;Strohmeyer;Prostate,2000

5. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation;Vartanian;Lab Invest,1995

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis;Biomarker Insights;2023-01

2. Recommendations and use of multiplex biomarker assays;Immunomodulatory Effects of Nanomaterials;2022

3. Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays;Biomedicines;2021-12-14

4. A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer;Theranostics;2021

5. Prognostic value of plasminogen activator inhibitor‐1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib;Health Science Reports;2020-10-15